Incorporating Health Technology Assessment (HTA) in Clinical Trials

In this webinar, the speakers will:

• Provide an overview of the current use and potential of HTA as a component of clinical trials aimed at regulatory approval of novel agents in various medical fields
• Introduce the general concept of HTA and cost-effectiveness in healthcare
• Discuss how these aspects are becoming an important requirement for market access and how the relevant additional elements can be incorporated and collected in a phase III clinical trial
• Illustrate the presentation with several examples, including clinical trials in which the authors have actively taken part as principal investigators and analysts
• Make tentative conclusions about future directions and the impact of HTA data in the drug-development process